{
    "success": true,
    "data": {
        "leverage": true,
        "derivatives": true,
        "swaps": true,
        "inverse": false,
        "replication_method": "synthetic",
        "ucits": false,
        "type": "ETP",
        "complex_factors": [
            "Significant Leverage (3x)",
            "Daily Compounding Effect",
            "Implied Synthetic Replication (via derivatives and margin account)",
            "Not a UCITS product (lacks non-complex presumption)",
            "Targeted at Sophisticated Investors",
            "KID Comprehension Alert present",
            "Index itself is leveraged and rebalanced daily"
        ],
        "classification": "complex",
        "supporting_data": "This product is classified as 'complex' under MiFID II based on several key factors. Firstly, it explicitly aims to provide '3 times the value of the daily performance' of its underlying asset, indicating significant leverage. MiFID II rules state that 'Significant leverage beyond UCITS limits makes an ETF complex'. Secondly, the document highlights a 'Compounding Effect', where holding the product for more than one day results in a return different from 3 times the reference asset's return over that period, due to 'daily leverage rebalancing'. This non-linear payoff structure and daily rebalancing, often associated with roll costs or similar effects in derivatives, makes the product's performance difficult to understand for an average retail investor. The product's structure, involving a 'Margin Account' and 'Collateral Assets' to achieve its leveraged objective, strongly implies the integral use of derivatives (such as total return swaps, even if not explicitly named) rather than physical replication. The provided rules state that if 'derivatives are integral to achieving its investment objective, such as using swaps or futures to replicate the index's performance', the product is complex. Furthermore, the rules specify that 'If any element of Contingent Convertible Bonds or any Swap usage is identified then the 'classification' must be 'complex''. The product is explicitly labeled as 'ETP Securities', not a UCITS ETF, thus it does not benefit from the UCITS presumption of non-complexity and must be assessed against the Article 38 criteria for 'other non-complex financial instruments' (which it fails). The Key Information Document (KID) itself contains a mandatory 'You are about to purchase a product that is not simple and may be difficult to understand' comprehension alert, which is a regulatory indicator of a complex product (MiFID II Rule 7). The 'Intended retail investor' section explicitly states the product is for 'sophisticated investors' who 'understand the risk of compounded returns and the increased risk of investment in leveraged products', directly contradicting the requirement for non-complex products to be easily understood by retail investors with basic knowledge. The product's highest risk rating (7 out of 7) also contributes to the overall assessment of complexity, especially as this risk is intrinsically linked to its leveraged and rebalancing structure. The ESMA guidance reinforces this, noting that 'complexity for the purposes of the Directive is determined by the way that an instrument is structured' and that 'all derivatives are assumed to be complex because their value is derived from another financial instrument or asset, adding a level of complexity to the understanding of the characteristics and valuation of those instruments'. The combination of high leverage, daily rebalancing, implicit derivative use, and the explicit comprehension warning in the KID unequivocally classifies this ETP as 'complex'."
    }
}